Great West Life Assurance CO Accelerate Diagnostics, Inc Transaction History

Great West Life Assurance CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.54 - $1.41 $1,070 - $2,796	-1,983 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$9.98 - $18.04 $397,473 - $718,479	-39,827 Reduced 95.26%	1,983 $21,000
Q3 2020 Nov 13, 2020	BUY	$9.98 - $18.04 $397,473 - $718,479	39,827 Added 2008.42%	41,810 $445,000
Q4 2019 Feb 11, 2020	BUY	$14.6 - $18.13 $28,951 - $35,951	1,983 New	1,983 $33,000
Q3 2019 Oct 25, 2019	SELL	$16.62 - $23.92 $42,414 - $61,043	-2,552 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$17.79 - $22.88 $68,366 - $87,927	-3,843 Reduced 60.09%	2,552 $0
Q1 2019 May 08, 2019	BUY	$11.76 - $22.15 $50,744 - $95,577	4,315 Added 207.45%	6,395 $134,000
Q3 2017 Nov 09, 2017	BUY	$21.1 - $25.15 $43,888 - $52,312	2,080	2,080 $46,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $174M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.